“CGM with infusion pump is very expensive for patients to buy. In India, hardly a few patients have CGM -  let alone infusion pumps. Now with newer technology I hope cost comes down and more patients have access to continuous monitoring. In Metropolitan cities around 5 % of the diabetic population would buy SMBG monitors.